In acute ischemic stroke, early IV tenecteplase was noninferior to alteplase for excellent functional outcome.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 36315948.
- Also identified by DOI 10.7326/J22-0090.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Menon BK, Buck BH, Singh N, et al. <b>Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.</b> Lancet. 2022;400:161-9. 35779553.
Medical subject headings
- Brain Ischemia
- Ischemic Stroke
- Tenecteplase
- Tissue Plasminogen Activator